Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hay

Showing results (161-170 of 299) with videos related to

Pageof 30
Sort By:
Journal of the American Chemical Society|June 24, 2004
Oxidation of 2-deoxyribose by benzotriazinyl radicals of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxidesSujata S Shinde, Robert F Anderson, Michael P Hay, et al.
Current Medical Research and Opinion|January 30, 2007
An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophreniaSandra L Tunis, Douglas E Faries, Michael D Stensland, et al.
Journal of the American Chemical Society|January 4, 2007
Structural criteria for the design of anion receptors: the interaction of halides with electron-deficient arenesOrion B Berryman, Vyacheslav S Bryantsev, David P Stay, et al.
Chemical Communications (Cambridge, England)|February 8, 2013
Capture and metathesis-based release of potassium salts by a multitopic ion receptorSung Kuk Kim, Benjamin P Hay, Jong Seung Kim, et al.
Biochemical Pharmacology|June 5, 2003
Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targetingYvette M Delahoussaye, Michael P Hay, Frederik B Pruijn, et al.
Journal of the American Chemical Society|June 24, 2004
Structural criteria for the rational design of selective ligands: convergent hydrogen bonding sites for the nitrate anionBenjamin P Hay, Maciej Gutowski, David A Dixon, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|May 25, 2004
Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the MythsGary S. Kabinoff, Patrick A. Toalson, Kristine Masur Healey, et al.
Journal of the American Chemical Society|September 24, 2009
Spin trapping of radicals other than the *OH radical upon reduction of the anticancer agent tirapazamine by cytochrome P450 reductaseSujata S Shinde, Michael P Hay, Adam V Patterson, et al.
Journal of Medicinal Chemistry|May 26, 1995
Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubilityM P Hay, H H Lee, W R Wilson, et al.
Journal of Medicinal Chemistry|December 4, 2003
Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapyMichael P Hay, Robert F Anderson, Dianne M Ferry, et al.
Pageof 30

Showing results (161-170 of 299) with videos related to

Sort By:
Pageof 30
Journal of the American Chemical Society|June 24, 2004
Oxidation of 2-deoxyribose by benzotriazinyl radicals of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxidesSujata S Shinde, Robert F Anderson, Michael P Hay, et al.
Current Medical Research and Opinion|January 30, 2007
An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophreniaSandra L Tunis, Douglas E Faries, Michael D Stensland, et al.
Journal of the American Chemical Society|January 4, 2007
Structural criteria for the design of anion receptors: the interaction of halides with electron-deficient arenesOrion B Berryman, Vyacheslav S Bryantsev, David P Stay, et al.
Chemical Communications (Cambridge, England)|February 8, 2013
Capture and metathesis-based release of potassium salts by a multitopic ion receptorSung Kuk Kim, Benjamin P Hay, Jong Seung Kim, et al.
Biochemical Pharmacology|June 5, 2003
Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targetingYvette M Delahoussaye, Michael P Hay, Frederik B Pruijn, et al.
Journal of the American Chemical Society|June 24, 2004
Structural criteria for the rational design of selective ligands: convergent hydrogen bonding sites for the nitrate anionBenjamin P Hay, Maciej Gutowski, David A Dixon, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|May 25, 2004
Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the MythsGary S. Kabinoff, Patrick A. Toalson, Kristine Masur Healey, et al.
Journal of the American Chemical Society|September 24, 2009
Spin trapping of radicals other than the *OH radical upon reduction of the anticancer agent tirapazamine by cytochrome P450 reductaseSujata S Shinde, Michael P Hay, Adam V Patterson, et al.
Journal of Medicinal Chemistry|May 26, 1995
Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubilityM P Hay, H H Lee, W R Wilson, et al.
Journal of Medicinal Chemistry|December 4, 2003
Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapyMichael P Hay, Robert F Anderson, Dianne M Ferry, et al.
Pageof 30